Variables | Groups | N | Percentages |
---|---|---|---|
Stage | 1 | 47 | 21.4 |
2 | 102 | 46.4 | |
3 | 57 | 25.9 | |
Not available | 14 | 6.3 | |
Grade | 1 | 29 | 13.2 |
2 | 80 | 36.4 | |
3 | 98 | 44.5 | |
Not available | 13 | 5.9 | |
Laterality | Right side | 110 | 50 |
Left side | 109 | 49.5 | |
Bilateral | 1 | 0.5 | |
T | 1 | 74 | 33.6 |
2 | 97 | 44.1 | |
3 | 37 | 16.8 | |
Not available | 12 | 5.5 | |
N | 0 | 92 | 41.8 |
1 | 82 | 37.3 | |
2 | 23 | 10.4 | |
3 | 18 | 8.2 | |
Not available | 5 | 2.3 | |
M | 0 | 220 | 100 |
aER | Negative | 60 | 27.3 |
Positive | 158 | 71.8 | |
Not available | 2 | 0.9 | |
bPR | Negative | 78 | 35.5 |
Positive | 140 | 63.6 | |
Not available | 2 | 0.9 | |
cHER-2 | Negative | 118 | 53.6 |
Equivocal | 67 | 30.5 | |
Overexpressed | 52 | 23.6 | |
Not available | 3 | 1.36 | |
Previous hormone therapy (PHT) | No PHT | 131 | 59.6 |
Has had PHT | 43 | 19.5 | |
Not available | 46 | 20.9 | |
Menopausal status | Premenopausal | 90 | 40.9 |
Postmenopausal | 109 | 49.5 | |
Not available | 21 | 9.6 |